Mereo BioPharma (MREO) Short term Debt (2017 - 2023)
Mereo BioPharma (MREO) posted quarterly Short term Debt of $5.2 million for Q2 2023, down 73.92% year-over-year from $20.1 million in Q2 2022, and down 59.71% quarter-over-quarter from $13.0 million in Q4 2022.
Mereo BioPharma (MREO) Short term Debt (2017 - 2023) Analysis & Trends
Mereo BioPharma (MREO) has reported Short term Debt for 6 consecutive years, with $5.2 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Short term Debt fell 73.92% year-over-year to $5.2 million; the TTM figure through Jun 2023 stood at $5.2 million (down 73.92% YoY), while the FY2022 annual figure was $13.0 million, changed N/A from the prior year.
- Short term Debt fell to $5.2 million in Q2 2023 per MREO's latest filing, from $13.0 million in the prior quarter.
- Across five years, Short term Debt topped out at $20.1 million in Q2 2022 and bottomed at $5.2 million in Q2 2023.
- Historically, Short term Debt has averaged $14.1 million across 4 years, with a median of $14.7 million in 2020.
- Annual changes were most pronounced in 2019 — Short term Debt surged 121.22% — and 2023, when it tumbled 73.92%.
- Mereo BioPharma's Short term Debt stood at $19.5 million in 2019, then dropped by 15.45% to $16.5 million in 2020, then slipped by 21.0% to $13.0 million in 2022, then tumbled by 59.71% to $5.2 million in 2023.
- Business Quant data shows MREO's Short term Debt at $5.2 million in Q2 2023, $13.0 million in Q4 2022, and $20.1 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.24 Mn |
| Dec 31, 2022 | 13.00 Mn |
| Jun 30, 2022 | 20.09 Mn |
| Jun 30, 2020 | 16.46 Mn |
| Dec 31, 2019 | 19.46 Mn |
| Jun 30, 2019 | 10.30 Mn |
| Dec 31, 2018 | 8.80 Mn |
| Dec 31, 2017 | 2.58 Mn |